86 related articles for article (PubMed ID: 15580706)
1. Strain-specific of alachlor on murine olfactory mucosal responses.
Genter MB; Goss KH; Groden J
Toxicol Pathol; 2004; 32(6):719-25. PubMed ID: 15580706
[TBL] [Abstract][Full Text] [Related]
2. Evolution of alachlor-induced nasal neoplasms in the Long-Evans rat.
Genter MB; Burman DM; Dingeldein MW; Clough I; Bolon B
Toxicol Pathol; 2000; 28(6):770-81. PubMed ID: 11127290
[TBL] [Abstract][Full Text] [Related]
3. Evidence for site-specific bioactivation of alachlor in the olfactory mucosa of the Long-Evans rat.
Wetmore BA; Mitchell AD; Meyer SA; Genter MB
Toxicol Sci; 1999 Jun; 49(2):202-12. PubMed ID: 10416265
[TBL] [Abstract][Full Text] [Related]
4. Comparison of rat olfactory mucosal responses to carcinogenic and non-carcinogenic chloracetanilides.
Genter MB; Warner BM; Medvedovic M; Sartor MA
Food Chem Toxicol; 2009 Jun; 47(6):1051-7. PubMed ID: 19425180
[TBL] [Abstract][Full Text] [Related]
5. Progression of alachlor-induced olfactory mucosal tumours.
Genter MB; Burman DM; Bolon B
Int J Exp Pathol; 2002 Dec; 83(6):303-8. PubMed ID: 12657139
[TBL] [Abstract][Full Text] [Related]
6. Molecular biology of the nasal airways: how do we assess cellular and molecular responses in the nose?
Genter MB
Toxicol Pathol; 2006; 34(3):274-80. PubMed ID: 16698726
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant perturbations in the olfactory mucosa of alachlor-treated rats.
Burman DM; Shertzer HG; Senft AP; Dalton TP; Genter MB
Biochem Pharmacol; 2003 Nov; 66(9):1707-15. PubMed ID: 14563481
[TBL] [Abstract][Full Text] [Related]
8. Genomic analysis of alachlor-induced oncogenesis in rat olfactory mucosa.
Genter MB; Burman DM; Vijayakumar S; Ebert CL; Aronow BJ
Physiol Genomics; 2002 Dec; 12(1):35-45. PubMed ID: 12419858
[TBL] [Abstract][Full Text] [Related]
9. Reduction of alachlor-induced olfactory mucosal neoplasms by the matrix metalloproteinase inhibitor Ro 28-2653.
Genter MB; Warner BM; Krell HW; Bolon B
Toxicol Pathol; 2005; 33(5):593-9. PubMed ID: 16178123
[TBL] [Abstract][Full Text] [Related]
10. Immunoblot analysis and immunohistochemical characterization of CYP2A expression in human olfactory mucosa.
Chen Y; Liu YQ; Su T; Ren X; Shi L; Liu D; Gu J; Zhang QY; Ding X
Biochem Pharmacol; 2003 Oct; 66(7):1245-51. PubMed ID: 14505803
[TBL] [Abstract][Full Text] [Related]
11. Acetochlor-induced rat nasal tumors: further studies on the mode of action and relevance to humans.
Green T; Lee R; Moore RB; Ashby J; Willis GA; Lund VJ; Clapp MJ
Regul Toxicol Pharmacol; 2000 Aug; 32(1):127-33. PubMed ID: 11029275
[TBL] [Abstract][Full Text] [Related]
12. Nasal cytochrome P450 2A: identification, regional localization, and metabolic activity toward hexamethylphosphoramide, a known nasal carcinogen.
Thornton-Manning JR; Nikula KJ; Hotchkiss JA; Avila KJ; Rohrbacher KD; Ding X; Dahl AR
Toxicol Appl Pharmacol; 1997 Jan; 142(1):22-30. PubMed ID: 9007030
[TBL] [Abstract][Full Text] [Related]
13. Differential xenobiotic induction of CYP2A5 in mouse liver, kidney, lung, and olfactory mucosa.
Su T; He W; Gu J; Lipinskas TW; Ding X
Drug Metab Dispos; 1998 Aug; 26(8):822-4. PubMed ID: 9698299
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of coumarin by rodent and human cytochromes P-450: metabolic basis of tissue-selective toxicity in olfactory mucosa of rats and mice.
Zhuo X; Gu J; Zhang QY; Spink DC; Kaminsky LS; Ding X
J Pharmacol Exp Ther; 1999 Feb; 288(2):463-71. PubMed ID: 9918546
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific expression of CYP2A5 in the mouse respiratory tract: effects of olfactory toxicants.
Piras E; Franzén A; Fernández EL; Bergström U; Raffalli-Mathieu F; Lang M; Brittebo EB
J Histochem Cytochem; 2003 Nov; 51(11):1545-55. PubMed ID: 14566026
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of the olfactory mucosa-specific Cyp2g1 gene: impact on acetaminophen toxicity in the lateral nasal gland, and tissue-selective effects on Cyp2a5 expression.
Zhuo X; Gu J; Behr MJ; Swiatek PJ; Cui H; Zhang QY; Xie Y; Collins DN; Ding X
J Pharmacol Exp Ther; 2004 Feb; 308(2):719-28. PubMed ID: 14610229
[TBL] [Abstract][Full Text] [Related]
17. Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.
Liu C; Zhuo X; Gonzalez FJ; Ding X
Mol Pharmacol; 1996 Oct; 50(4):781-8. PubMed ID: 8863822
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the carcinogenic potential of the herbicide alachlor to man.
Heydens WF; Wilson AG; Kier LD; Lau H; Thake DC; Martens MA
Hum Exp Toxicol; 1999 Jun; 18(6):363-91. PubMed ID: 10413243
[TBL] [Abstract][Full Text] [Related]
19. Update on olfactory mucosal metabolic enzymes: age-related changes and N-acetyltransferase activities.
Genter MB
J Biochem Mol Toxicol; 2004; 18(4):239-44. PubMed ID: 15452881
[TBL] [Abstract][Full Text] [Related]
20. CYP2A5-mediated activation and early ultrastructural changes in the olfactory mucosa: studies on 2,6-dichlorophenyl methylsulfone.
Franzén A; Carlsson C; Hermansson V; Lang M; Brittebo EB
Drug Metab Dispos; 2006 Jan; 34(1):61-8. PubMed ID: 16221755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
